Literature DB >> 862504

Calcium metabolism in amyotrophic lateral sclerosis.

L E Mallette, B Patten, J D Cook, W K Engel.   

Abstract

Calcium metabolism was studied prospectively in 12 patients with amyotrophic lateral sclerosis. Two patients showed mild hypocalcemia, malabsorption of calcium, and elevated plasma parathyroid hormone concentrations. Serum 25-hydroxyvitamin D was decreased in one and low-normal in the second. These two patients and a third showed aminoaciduria on thin layer chromatography. Calcium metabolism was apparently restored to normal by dihydrotachysterol, a vitamin D analog, but no improvement in neurologic function resulted. Bone radiographs taken in search of metabolic bone disease showed a significant increase in the incidence of congenital vertebral anomalies in the ALS patients (50% versus 8%). The relationship of the abnormalities in calcium metabolism and in vertebral structure to the etiology of motor neuron disease is not known.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 862504

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN: 0012-3714


  7 in total

1.  Models of environmentally induced neurological disease: epidemiology and etiology of amyotrophic lateral sclerosis and parkinsonism-dementia in the Western Pacific.

Authors:  R M Garruto; R Yanagihara; D C Gajdusek
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

2.  Association of fractures with the incidence of amyotrophic lateral sclerosis.

Authors:  Tracy L Peters; Caroline E Weibull; Fang Fang; Dale P Sandler; Paul C Lambert; Weimin Ye; Freya Kamel
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-03-20       Impact factor: 4.092

3.  Fine structural correlations between the muscle pathology of amyotrophic lateral sclerosis (ALS) patients and experimental Ca-Mg deficient rats.

Authors:  T Kumamoto; C Suematsu; Y Yata; Y Yase
Journal:  Experientia       Date:  1979-12-15

4.  Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System.

Authors:  Anna Gaimari; Michele Fusaroli; Emanuel Raschi; Elisa Baldin; Luca Vignatelli; Francesco Nonino; Fabrizio De Ponti; Jessica Mandrioli; Elisabetta Poluzzi
Journal:  Drug Saf       Date:  2022-05-24       Impact factor: 5.606

5.  Blood Lead, Bone Turnover, and Survival in Amyotrophic Lateral Sclerosis.

Authors:  Fang Fang; Tracy L Peters; John D Beard; David M Umbach; Jean Keller; Daniela Mariosa; Kelli D Allen; Weimin Ye; Dale P Sandler; Silke Schmidt; Freya Kamel
Journal:  Am J Epidemiol       Date:  2017-11-01       Impact factor: 4.897

Review 6.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

7.  Breathlessness in amyotrophic lateral sclerosis: A case report on the role of osteoporosis in the worsening of respiratory failure.

Authors:  Simona Portaro; Elisabetta Morini; Maria Elena Santoro; Maria Accorinti; Pietro Marzullo; Antonino Naro; Rocco Salvatore Calabrò
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.